Global Dronabinol Market Growth 2025-2031
Description
The global Dronabinol market size is predicted to grow from US$ 267 million in 2025 to US$ 392 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Global key players of Dronabinol include Canopy Growth, Noramco, THC Pharm, Echo Pharmaceuticals, BOL Pharma and Aphios Corporation, etc. Top five players occupy for a share about 44%. North America is the largest market, with a share about 58%, followed by Europe and Asia-Pacific. In terms of product, Synthetic Dronabinol is the largest segment, with a share over 86%. In terms of application, Capsule is the largest market, with a share over 66%.
LP Information, Inc. (LPI) ' newest research report, the “Dronabinol Industry Forecast” looks at past sales and reviews total world Dronabinol sales in 2024, providing a comprehensive analysis by region and market sector of projected Dronabinol sales for 2025 through 2031. With Dronabinol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dronabinol industry.
This Insight Report provides a comprehensive analysis of the global Dronabinol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dronabinol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dronabinol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dronabinol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dronabinol.
This report presents a comprehensive overview, market shares, and growth opportunities of Dronabinol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Synthetic Dronabinol
Natural Dronabinol
Segmentation by Application:
Capsule
Oral Liquid
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dronabinol market?
What factors are driving Dronabinol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dronabinol market opportunities vary by end market size?
How does Dronabinol break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Global key players of Dronabinol include Canopy Growth, Noramco, THC Pharm, Echo Pharmaceuticals, BOL Pharma and Aphios Corporation, etc. Top five players occupy for a share about 44%. North America is the largest market, with a share about 58%, followed by Europe and Asia-Pacific. In terms of product, Synthetic Dronabinol is the largest segment, with a share over 86%. In terms of application, Capsule is the largest market, with a share over 66%.
LP Information, Inc. (LPI) ' newest research report, the “Dronabinol Industry Forecast” looks at past sales and reviews total world Dronabinol sales in 2024, providing a comprehensive analysis by region and market sector of projected Dronabinol sales for 2025 through 2031. With Dronabinol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dronabinol industry.
This Insight Report provides a comprehensive analysis of the global Dronabinol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dronabinol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dronabinol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dronabinol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dronabinol.
This report presents a comprehensive overview, market shares, and growth opportunities of Dronabinol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Synthetic Dronabinol
Natural Dronabinol
Segmentation by Application:
Capsule
Oral Liquid
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing
Key Questions Addressed in this Report
What is the 10-year outlook for the global Dronabinol market?
What factors are driving Dronabinol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dronabinol market opportunities vary by end market size?
How does Dronabinol break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
102 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Dronabinol by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Dronabinol by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
